The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2
Open Access
- 6 March 2021
- Vol. 13 (3), 425
- https://doi.org/10.3390/v13030425
Abstract
Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection is the cause of a worldwide pandemic, currently with limited therapeutic options. The spike glycoprotein and envelope protein of SARS-CoV-2, containing disulfide bridges for stabilization, represent an attractive target as they are essential for binding to the ACE2 receptor in host cells present in the nasal mucosa. Bromelain and Acetylcysteine (BromAc) has synergistic action against glycoproteins by breakage of glycosidic linkages and disulfide bonds. We sought to determine the effect of BromAc on the spike and envelope proteins and its potential to reduce infectivity in host cells. Recombinant spike and envelope SARS-CoV-2 proteins were disrupted by BromAc. Spike and envelope protein disulfide bonds were reduced by Acetylcysteine. In in vitro whole virus culture of both wild-type and spike mutants, SARS-CoV-2 demonstrated a concentration-dependent inactivation from BromAc treatment but not from single agents. Clinical testing through nasal administration in patients with early SARS-CoV-2 infection is imminent.Keywords
Funding Information
- Mucpharm pty ltd (COVID research)
This publication has 56 references indexed in Scilit:
- The role of cellular oxidoreductases in viral entry and virus infection-associated oxidative stress: potential therapeutic applicationsEmerging Therapeutic Targets, 2015
- A formulation for in situ lysis of mucin secreted in pseudomyxoma peritoneiInternational Journal of Cancer, 2013
- N-acetylcysteine Enhances Cystic Fibrosis Sputum Penetration and Airway Gene Transfer by Highly Compacted DNA NanoparticlesMolecular Therapy, 2011
- Significant Redox Insensitivity of the Functions of the SARS-CoV Spike GlycoproteinOnline Journal of Public Health Informatics, 2006
- Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2The EMBO Journal, 2005
- Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction.Proceedings of the National Academy of Sciences of the United States of America, 1994
- The Effect of Enzymes on Structural and Biological Properties of Semliki Forest VirusJournal of General Virology, 1974
- Location of the Glycoprotein in the Membrane of Sindbis VirusNature New Biology, 1971